SARS-CoV-2 (COVID-19) Envelope protein, His and Avi tag
Cat# GTX01547-pro-100ug
Size : 100ug
Brand : Genetex
Species | SARS Coronavirus 2 |
---|---|
Package | 100 μg |
View product citations for antibody GTX01547-pro on CiteAb
PROPERTIES
Form
Liquid
Buffer
Filter-sterilized 20mM Tris, 250mM NaCl, 0.5% Triton X-100
Preservative
No preservative
Storage
Store as concentrated solution. Aliquot and store at -20ºC or below. Avoid freeze-thaw cycles.
Concentration
Batch dependent (Please refer to the vial label for the specific concentration.)
Region/Sequence
Met1-Val75 of SARS-CoV-2 (COVID-19) Envelope protein (Accession #QHD43418.1) fused with a 6×His, Avi tag at the N-terminus.
Expression System
E. coli
Purity
> 92% by SDS-PAGE
Endotoxin
< 0.1 EU/μg (determined by LAL method)
Conjugation
Unconjugated
Note
For laboratory research use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
Purchasers shall not, and agree not to enable third parties to, analyze, copy, reverse engineer or otherwise attempt to determine the structure or sequence of the product.
TARGET
Synonyms
SARS-CoV-2 Envelope , COVID-19 Envelope
Database
DATA IMAGES
GTX01547-pro ImageSDS-PAGE of GTX01547-pro SARS-CoV-2 (COVID-19) Envelope protein |
Application Reference
Syeda Warisul Fatima et al. Phytomed Plus 2022; 2 (2) : 100241 Molecular and structural insights of β-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors.
REVIEW
Application Reference
Syeda Warisul Fatima et al. Phytomed Plus 2022; 2 (2):100241 Molecular and structural insights of β-boswellic acid and glycyrrhizic acid as potent SARS-CoV-2 Envelope protein inhibitors.
You might also be interested by the following products:
Cat#
Description
Cond.
Price Bef. VAT